Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: Implications for short-term dual anti-platelet therapy.

[1]  M. Price,et al.  Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. , 2020, The New England journal of medicine.

[2]  R. Virmani,et al.  Drug-eluting coronary stents: insights from preclinical and pathology studies , 2019, Nature Reviews Cardiology.

[3]  H. Okayama,et al.  Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. , 2019, JAMA.

[4]  R. Virmani,et al.  Thromboresistance and Functional Healing in the COBRA PzF Stent versus Competitor DES: Implications for Dual Anti-Platelet Therapy. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  M. Stoel,et al.  Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial , 2018, The Lancet.

[6]  W. Desmet,et al.  Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis , 2017, Circulation.

[7]  M. Stoel,et al.  Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial , 2017, JAMA cardiology.

[8]  Laura Mauri,et al.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.

[9]  F. Eberli,et al.  Polymer-free Drug-Coated Coronary Stents. , 2016, The New England journal of medicine.

[10]  J. Hirsh,et al.  Medical device‐induced thrombosis: what causes it and how can we prevent it? , 2015, Journal of thrombosis and haemostasis : JTH.

[11]  Samin K. Sharma,et al.  Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. , 2015, Journal of the American College of Cardiology.

[12]  A. Finn,et al.  Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration. , 2015, Pharmacological research.

[13]  A. Finn,et al.  Sirolimus-FKBP12.6 Impairs Endothelial Barrier Function Through Protein Kinase C-&agr; Activation and Disruption of the p120–Vascular Endothelial Cadherin Interaction , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[14]  R. Latour,et al.  The adherence of platelets to adsorbed albumin by receptor-mediated recognition of binding sites exposed by adsorption-induced unfolding. , 2010, Biomaterials.

[15]  A. Hotta,et al.  Fluorine doping into diamond-like carbon coatings inhibits protein adsorption and platelet activation. , 2007, Journal of biomedical materials research. Part A.

[16]  E. Edelman,et al.  Cardiology is flow. , 2006, Circulation.

[17]  A. Malik,et al.  Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.

[18]  R. Virmani,et al.  Drug eluting stents: are human and animal studies comparable? , 2003, Heart.

[19]  M. Corada,et al.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Edelman,et al.  Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.

[21]  J M Courtney,et al.  Biomaterials for blood-contacting applications. , 1994, Biomaterials.

[22]  D. Lyman,et al.  The effect of chemical structure and surface properties of synthetic polymers on the coagulation of blood. III. In vivo adsorption of proteins on polymer surfaces. , 1974, Transactions - American Society for Artificial Internal Organs.